![](/img/cover-not-exists.png)
Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib
Janjigian, Y. Y., Azzoli, C. G., Krug, L. M., Pereira, L. K., Rizvi, N. A., Pietanza, M. C., Kris, M. G., Ginsberg, M. S., Pao, W., Miller, V. A., Riely, G. J.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-10-2662
Date:
April, 2011
File:
PDF, 286 KB
english, 2011